U.S. patent agent Ainslie Little will be speaking at the Association of University Technology Managers’ (AUTM) annual meeting, “Riding the Regenerative Medicine Commercialization Wave: What You Need to Know,” on March 14.
Ainslie will be discussing commercializing regenerative medicine (RM), as well as “developments and practical guidance for technology transfer offices operating in the RM space.”